Press Releases
- Active Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference September 5, 2013 08:30 (CEST)
- Active Biotech AB Interim Report January - June 2013 August 7, 2013 08:30 (CEST)
- TEVA AND ACTIVE BIOTECH REPORT POSITIVE RESULTS FROM PHASE IIa STUDY OF LAQUINIMOD IN ACTIVE LUPUS NEPHRITIS June 12, 2013 14:00 (CEST)
- Impact of Active Biotech's candidate drug tasquinimod on bone metastases presented at ASCO June 3, 2013 15:00 (CEST)
- Active Biotech's project ANYARA improved overall survival in a subgroup of renal cell cancer patients June 3, 2013 15:00 (CEST)
- Active Biotech to Present at the Jefferies 2013 Global Healthcare Conference May 30, 2013 10:00 (CEST)
- Annual General Meeting of Active Biotech AB May 16, 2013 08:30 (CEST)
- New data to be presented at the 2013 ASCO Annual Meeting show Active Biotech's commitment to oncology research May 16, 2013 08:30 (CEST)
- Active Biotech AB Interim Report January - March 2013 April 25, 2013 08:30 (CEST)
- Active Biotech and Ipsen update the analysis plan for the 10TASQ10 trial evaluating tasquinimod in the treatment of prostate cancer April 25, 2013 07:00 (CEST)